COVID, FDA and local vaccine
Digest more
Moderna said on Wednesday it has withdrawn an application seeking approval for its flu and COVID combination vaccine candidate after discussions with the U.S. Food and Drug Administration.
The agency will narrow its approval for updated coronavirus vaccines, marking a significant shift in the agency’s approach to green-lighting shots that have been recommended broadly to the public.
Federal health officials will no longer routinely approve annual COVID-19 shots for younger adults and children who are healthy
Explore more